Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication. | ||||||||
|
Bipolar disorder and polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1).Mohammadynejad P, Saadat I, Ghanizadeh A, Saadat M Department of Biology, College of Sciences, Shiraz University, Shiraz 71454, Iran. Glutathione S-transferases are ubiquitous multifunctional enzymes, which play a key role in cellular detoxification. The present case-control study was performed in Shiraz, Iran to investigate the association between polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1) and susceptibility to bipolar disorder (BPD). A total of 228 BPD patients participated in the study. In addition, 236 healthy blood donors, who frequency matched with the patients according to age and gender, were also studied as a control group. Statistical analysis revealed that polymorphisms of neither GSTM1 (OR=0.73, 95% CI: 0.50-1.05) nor GSTT1 (OR=0.98, 95% CI: 0.65-1.47) were associated with risk of BPD. Patients were stratified according to their age of onset into early onset (below 19 years old) and late onset (more than 19 years old) groups. Among the early onset group, the GSTM1 null genotype decreases the risk of BPD (OR=0.43, 95% CI: 0.24-0.79). Further analysis showed that a combination of "GSTM1 positive genotype and GSTT1 null genotype" versus "positive genotypes of GSTM1 and GSTT1" increased the risk of BPD (OR=2.28, 95% CI: 1.07-4.85). However, there was no significant association between the study polymorphisms and risk of BPD among the late onset group. The present finding indicated that GSTM1 and GSTT1 are candidate polymorphisms for susceptibility to BDP among adolescents. Published 28 February 2011 in Psychiatry Res, 186(1): 144-6.
© 2004-2013 Bipolar Research Today. All Rights Reserved. |
| ||||||
